$NSP

INSPERITY, INC. (NSP): Results of Operations and Financial Condition

INSPERITY, INC. (NSP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Insperity Announces Second Quarter Results HOUSTON – July 29, 2026 – Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, today reported results for the second quarter ended June 30, 2026

Original reporting
Published Jul 29, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 8:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$NSP
Bullish
medium confidence
Mentioned
$NSP
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NSPBullishMed
01

Why it matters

Key decision points are the updated 2026 adjusted EPS and adjusted EBITDA ranges, and whether the margin recovery plan is offsetting weaker paid WSEE trends and higher benefits costs per covered employee.

02

Market read

This is a primary earnings and guidance update with quantified profitability and outlook ranges, which can drive re-pricing of expectations for 2026 margin recovery.

03

What to watch

Workday strategic partnership costs are explicitly referenced in operating expenses; traders may reassess whether partnership-related spend is stabilizing or still pressuring GAAP profitability despite adjusted improvements.

Relevance 7/10Novelty 7/10Timing: after-hours, filed 8-K with Q2 results and updated 2026 guidance

Background

The 8-K (Item 2.02) reports Insperity’s Q2 ended June 30, 2026 results and provides updated 2026 guidance, discussed on a same-day 5:00 p.m. ET call.

Company-level read

Ticker impact

$NSPBullishMedium confidence
Context

Insperity reported Q2 results and updated 2026 guidance, including adjusted EPS of $0.34 and full-year adjusted EPS range of $1.88 to $2.43.

Expected impact

Near-term bias likely positive if investors focus on margin recovery and the updated adjusted EPS/EBITDA ranges; watch for any skepticism around YTD net income decline and paid WSEE softness.

Evidence & confidence

The filing is a primary earnings/guidance disclosure with multiple quantified metrics (EPS, EBITDA, WSEE, and 2026 ranges). However, the text also shows YTD net income and diluted EPS down 20%, which can temper the reaction.

Market effects

HR services and payroll/benefits outsourcing peers may see read-across on margin recovery and worksite employee (WSEE) trends.

Primarily US-focused HR services demand and pricing dynamics.

Limited direct global impact; mostly domestic workforce/benefits administration economics.

Counterpoint

Investors may discount adjusted metrics if GAAP net income and diluted EPS are still down YTD, implying the margin recovery may not yet translate into bottom-line earnings power.

Key entities

  • Insperity, Inc.

    NYSE-listed HR and business performance solutions provider reporting Q2 results and updated 2026 guidance.

  • Workday strategic partnership

    Operating expense includes specified Workday partnership-related costs in both Q2 and YTD periods.

Related articles

$NSPMedAI 8/10

Insperity (NSP) Stock Trades Down, Here Is Why

Insperity (NYSE: NSP) shares fell about 7.3% after its Q2 results and full-year guidance. The company reported adjusted EPS above its midpoint, but benefits costs per covered employee rose 5.2% and total gross profit fell 3%. Guidance also pointed to paid worksite employees declining about 1% to 1.6% in 2026.

$NSPMed

Insperity (NYSE:NSP) Surprises With Q2 CY2026 Sales

Insperity (NYSE:NSP) reported Q2 CY2026 revenue of $1.69 billion, up 1.7% year over year, beating Wall Street’s revenue estimate by 0.7%. Non-GAAP adjusted EPS was $0.34, up from $0.26, and 6.9% above consensus. The article cites full-year EPS expected to rise from $0.85 to $2.34.

$IBKRMedAI 8/10

Interactive Brokers Earns Interest on $182 Billion of Its Clients' Idle Cash. Will Anthropic's IPO Drain It?

Interactive Brokers (IBKR) reported $182.4B in uninvested client cash, up 27% YoY, earning interest until invested. Anthropic's potential $2T IPO could impact cash levels, but SpaceX's IPO didn't drain IBKR's reserves. IBKR's Q2 net interest income rose 23% to $1.06B, half of total revenues. Client accounts and trading activity grew, mitigating cash outflows. IBKR stock is near $92, trading at 29x next year's earnings.

$ORCLMedAI 8/10

Oracle’s AI Earnings Story Is Improving, but the Cash Flow Test Remains

Oracle (ORCL) reported strong Q4 earnings with 21% revenue growth and raised its profit forecast. Morgan Stanley increased its price target to $210, citing improved GPUaaS margins. However, the company faces cash flow pressure due to high capital expenditures for AI infrastructure, with free cash flow at negative $23.7 billion. Hedge funds remain invested, with Fisher Asset Management increasing its stake.

$AVGOMedAI 9/10

Broadcom’s AI Forecast Suggests Hyperscalers Want More Than Just Nvidia GPUs

Broadcom (AVGO) raised its AI chip revenue forecast to $115B for FY2027, up from $100B, and expects $230B in FY2028. This reflects Big Tech's demand for custom chips and networking components, reducing reliance on Nvidia (NVDA). KeyBanc reiterated an Overweight rating and $575 price target for AVGO. AVGO's Q3 revenue rose 86% YoY to $29.6B, but Q4 guidance was slightly below expectations. Hedge funds hold positions in both AVGO and NVDA, with Fisher Asset Management among the top holders.